VVT Med (VVTM.V) Stock Price

VVT Med Price

OTC·CLOSED
0.14
​
Market closed

Revenue at VVT Med has contracted by 20.2% per year over the past 17 years to 125,285.13 USD. VVT Med's net margin stands at -4,467.4%, down from 2,066.7% several years earlier.

VVT Med stock price

Access this data via the Eulerpool API

VVT Med business model & stock analysis

DXI Capital Corp. acquires, explores for, and develops energy projects with a focus on oil and gas exploration in Canada and the United States. The company is headquartered in Vancouver, British Columbia and currently employs 10 full-time employees. The company went IPO on 2001-07-17. The firm is in the business of exploring and developing energy properties with a focus on oil and gas in North America. The Company’s wholly0wned subsidiaries are Dejour Energy (USA) Corp. and 0855524 B.C. Ltd.

Frequently asked questions about VVT Med

Converted at the current exchange rate, the VVT Med share trades at 0.13 EUR (0.14 USD).

The revenue cannot currently be calculated for VVT Med.

The profit cannot currently be calculated for VVT Med.

The P/E ratio cannot be calculated for VVT Med at the moment.

The P/S cannot be calculated for VVT Med currently.

The Eulerpool Quality Score for VVT Med is 2/10.

The ISIN of VVT Med is CA91841T1084. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of VVT Med is A2QEQ8. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of VVT Med is VVTM.V. The ticker symbol is used to trade VVT Med shares on the stock exchange.

Fair ValueTerminal
0.12 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Oil, Gas & Consumable Fuels
Number of shares
Employees
Revenue per Employee
12,528.51 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
USD
Initial public offering
Jul 17, 2001
ISIN
CA91841T1084
Cusip
267473106
Sedol
BN7KGV6
Market capitalization
9.39 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
4.49
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
218.46 %
Last updated Oct 10, 2026, 11:55 AM

VVT Med Peer Group

VVT Med Ticker

OTC · DXIEF

All fundamentals and in-depth analysis of VVT Med

Our stock analysis for VVT Med stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of VVT Med. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.